JournalTOCs

Experimental Hematology & Oncology
Journal Prestige (SJR): 0.842

Citation Impact (citeScore): 2
Number of Followers: 6

This is an Open Access Journal

Open Access journal
ISSN (Online) 2162-3619
Published by BMC (Biomed Central)

[280 journals]

Advancing precision antibody-drug conjugate therapy: unique proteogenomic
profiles of tumor subsets in non-small cell lung cancer
- Authors: Edwin Lin; Ying-Chun Lo, Vivek Subbiah, Rajat Thawani Aakash Desai
  Abstract: Antibody-drug conjugates (ADCs) represent a promising therapeutic strategy for non-small cell lung cancer (NSCLC), targeting tumor-specific antigens with precision. However, the molecular heterogeneity of NSCL...
  PubDate: 2025-07-11T00:00:00Z
Reduced morbidity and mortality of cGVHD in patients who received
treatment with mesenchymal stromal cells for steroid-resistant aGVHD:
long-term follow-up of a randomized phase 3 trial
- Authors: Ke Zhao; Ren Lin, Zhiping Fan, Zhen Li, Xiaoyong Chen, Li Xuan, Fen Huang, Na Xu, Xiuli Wu, Shaohua Chen, Jing Sun, Xi Zhang, Jianyu Weng, Yonghua Li, Yuhua Li, Dongjun Lin…
  Abstract: Our open-label, multicenter, randomized, phase 3 trial showed that the incidence and severity of chronic graft-versus-host disease (cGVHD) reduced in steroid-resistant acute graft-versus-host disease (aGVHD) p...
  PubDate: 2025-07-09T00:00:00Z
Recent advances and challenges of cellular immunotherapies in lung cancer
treatment
- Authors: Chengfei Yang; Yue Liu, Ziqi Huang, Sijin Liu, Xi Zhang, Quanxing Liu Jigang Dai
  Abstract: Lung cancer is a major malignant tumor with high morbidity and fatality rates. For many years, traditional treatments for lung cancer have struggled to achieve a favorable outlook and prognosis. It is crucial ...
  PubDate: 2025-07-07T00:00:00Z
iPSC-derived NK cells engineered with CD226 effectively control acute
myeloid leukemia
- Authors: Runze Cai; Binyan Lu, Xiangyu Zhao, Shixin Zhou Yang Li
  Abstract: CD226 plays a vital role in NK cell cytotoxicity, interacting with its ligands on tumor targets. Acute myeloid leukemia (AML) cells have developed mechanisms to escape NK cell cytotoxicity, including inducing ...
  PubDate: 2025-07-07T00:00:00Z
Prophylactic infusion of allogeneic double-negative T cells as immune
modulators to prevent relapse in high-risk AML patients post-Allo-HSCT: a
phase I trial
- Authors: Guangyu Sun; Xingchi Chen, Tianzhong Pan, Kaidi Song, Haicun Xie, Meijuan Tu, Xiang Wan, Wen Yao, Yaxin Cheng, Ziwei Zhou, Dongyao Wang, Yongsheng Han, Baolin Tang, Liming Yang Xiaoyu Zhu
  Abstract: Relapse remains a major challenge for high-risk acute myeloid leukemia (AML) patients following allogeneic hematopoietic stem cell transplantation (allo-HSCT). In our first-in-human Phase I trial (ChiCTR-19000...
  PubDate: 2025-07-02T00:00:00Z

HOME > Browse the 73 Subjects covered by JournalTOCs
Subject	Total Journals